Select Bibliography

Select Bibliography

Filter by any of these (after searching):

Federally Funded Research

There are 141 items

Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia

PubMed

PMC

QxMD

DOI

Google Scholar

Alachkar, Houda , Fulton, Noreen , Sanford, Ben , Malnassy, Greg ... - - Pharmacogenomics J. - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-10102

Symptoms and limb changes for breast cancer survivors treated with neoadjuvant chemotherapy: Lymphedema results of ACOSOG Z1071 (Alliance)

Google Scholar

Armer, Jane M. , Ballman, Karla , McCall, Linda , Suman, Vera ... - MASCC / ISOO - Supportive Cancer Care - 2017

Abstract - Secondary Endpoint - Primary Analysis - Breast - ACOSOG-Z1071

Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Augert, Arnaud , Zhang, Qing , Bates, Breanna , Cui, Min ... - - J Thorac Oncol - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Sequencing - CALGB-151111

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Baggstrom, Maria Q. , Socinski, Mark A. , Wang, Xiaofei F. , Gu, Lin ... - - J Thorac Oncol - 2017

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30607 , CALGB-70701

Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy

PubMed

PMC

QxMD

DOI

Google Scholar

Beltran, Himisha , Wyatt, Alexander W , Chedgy, Edmund C ... - - Clin. Cancer Res. - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90203

Acute myeloid leukemia (AML) patients with an isolated trisomy display increased frequency of spliceosome mutations CALGB 8461 and 20202 (Alliance)

Google Scholar

Bhatnagar, Bhavana , Eisfeld, Ann-Kathrin , Mrózek, Krzysztof ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461

Mutational Landscape and Clinical Outcome Associated with Different Rearrangements Involving 11q23/MLL in De Novo Acute Myeloid Leukemia (AML) CALB 8461 and 20202 (Alliance)

Google Scholar

Bill, Marius , Eisfeld Ann-Kathrin , Mrózek Krzysztof ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461

Alliance A071101: A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) Vaccine Given with Bevacizumab versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma

Google Scholar

Bloch, Orin , Shi, Qian , Anderson, S. Keith , Knopp, Michael ... - SNO - Neuro-Oncology - 2017

Abstract - Primary Endpoint - Primary Analysis - Neuro-Onc - A071101

Cognitive Function and Discontinuation of Adjuvant Hormonal Therapy in Older Breast Cancer Survivors: CALGB 369901 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Bluethmann, Shirley M. , Alfano, Catherine M. , Clapp, Jonathan D. ... - - Breast Cancer Res. Treat. - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901

Randomized phase 2 trial of ofatumumab and bendamustine versus ofatumumab, bendamustine and bortezomib induction and maintenance therapy in patients (pts) with previously untreated high risk follicular lymphoma (FL): results from CALGB 50904 (Alliance)

Google Scholar

Blum, Kristie A. , Jung, Sin-Ho , Barak, Ian , Hsi, Eric D. ... - ASH - Blood - 2017

Abstract - Primary Endpoint - Primary Analysis - Lymphoma - CALGB-50904

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B study (CALGB 10503)

PubMed

PMC

QxMD

DOI

Google Scholar

Blum, William , Sanford, Ben L. , Klisovic, Rebecca ... - - Leukemia - 2017

Manuscript - Primary Endpoint - Primary Analysis - Leukemia - CALGB-10503

Tumor Biology and Response to Chemotherapy Impact Breast Cancer-Specific Survival in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Long-term Follow-up from ACOSOG Z1071 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Boughey, Judy C. , Ballman, Karla V. , McCall, Linda M. ... - - Ann. Surg. - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Breast - ACOSOG-Z1071

Tumor biology and response to chemotherapy impact breast cancer specific survival in node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection: Results from ACOSOG Z1071 (Alliance)

Google Scholar

Boughey, Judy C. , Ballman, Karla , McCall, Linda , Byrd, David ... - ASA - - 2017

Abstract - Secondary Endpoint - Long-Term-Followup Analysis - Breast - ACOSOG-Z1071

Predictors of locoregional recurrence after neoadjuvant chemotherapy and surgery for node positive breast cancer: Results from ACOSOG Z1071 (Alliance)

Google Scholar

Boughey, Judy C. , Ballman, Karla , McCall, Linda ... - SABCS - Cancer Res. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z1071

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

PubMed

PMC

QxMD

DOI

Google Scholar

Brown, Paul D , Ballman, Karla V , Cerhan, Jane H , Anderson, S Keith ... - - Lancet Oncol. - 2017

Manuscript - Primary Endpoint - Primary Analysis - Neuro-Onc - N107C

Comparison of Residual Cancer Burden, American Joint Committee on Cancer staging and Pathologic Complete Response in Breast Cancer after Neoadjuvant Chemotherapy: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

PubMed

PMC

QxMD

DOI

Google Scholar

Campbell, Jeffrey I. , Yau, Christina , Krass, Polina , Moore, Dan ... - - Breast Cancer Res. Treat. - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Breast - CALGB-150007

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

PubMed

PMC

QxMD

DOI

Google Scholar

Choueiri, Toni K. , Halabi, Susan , Sanford, Ben L. , Hahn, Olwen ... - - J. Clin. Oncol - 2017

Manuscript - Primary Endpoint - Primary Analysis - GU - A031203

Progression-free survival (PFS) by independent review results from ALLIANCE A031203 trial (CABOSUN): cabozantinib versus sunitinib as initial targeted therapy for patients (pts) with metastatic renal cell carcinoma (mRCC)

Google Scholar

Choueiri, Toni K. , Hessel, Colin , Halabi, Susan , Sanford, Ben ... - ESMO - Ann Oncol - 2017

Abstract - Primary Endpoint - Primary Analysis - GU - A031203

Stereotactic Radiosurgery with or without Whole Brain Radiotherapy for Limited Brain Metastases: A Secondary Analysis of the NCCTG N0574 (Alliance) Randomized Controlled Trial

PubMed

PMC

QxMD

DOI

Google Scholar

Churilla, Thomas M. , Ballman, Karla V. , Brown, Paul D. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Neuro-Onc - N0574

Clinical and Genome Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Dolan, M. Eileen , El Charif, Omar , Wheeler, Heather E. ... - - Clin. Cancer Res. - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - PPP - CALGB-90401

Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Durá-Ferrandis, Estrella , Mandelblatt, Jeanne S. , Clapp, Jonathan ... - - Psychooncology - 2017

Manuscript - Secondary Endpoint - Long-Term-Followup Analysis - Older Adult - CALGB-369901

Prognostic impact of NPM1/FLT3-ITD genotypes from randomized patients treated within the RATIFY/CALGB 10603 (Alliance) Study

Google Scholar

Döhner, Konstanze , Thiede, Christian , Larson, Richard A. ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - CALGB-10603

A multi-center phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401)

Google Scholar

D’Angelo, Sandra P. , Mahoney, Michelle R. , Van Tine, Brian ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Primary Endpoint - Primary Analysis - Experimental - A091401

Final Results of a phase III trial of celecoxib (C) in addition to standard chemotherapy for advanced NSCLC with COX- 2 overexpression: CALGB 30801 (Alliance)

Google Scholar

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - MSTO - Int. J. Radiat. Oncol. Biol. Phys. - 2017

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30801

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - - J. Clin. Oncol - 2017

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30801

Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality

PubMed

PMC

QxMD

DOI

Google Scholar

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia

PubMed

PMC

QxMD

DOI

Google Scholar

Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Schwind, Sebastian ... - - Leukemia - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Ellis, Matthew J. , Suman, Vera J. , Hoog, Jeremy ... - - J. Clin. Oncol - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Breast - ACOSOG-Z1031B

Nut Consumption and Survival in Stage III Colon Cancer Patients: Results from CALGB 89803 (Alliance)

DOI

Google Scholar

Fadelu, Temidayo , Sui Zhang , Donna Niedzwiecki , Xing Ye ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-89803

Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): Update of the SOFT trial

DOI

Google Scholar

Fleming, Gini F , Francis, Prudence A , Láng, István ... - SABCS - Ann. Oncol. - 2017

Abstract - Primary Endpoint - Primary Analysis - Breast - IBCSG-24-02 (SOFT-TEXT)

Comparative “Nocebo Effects” in Older Patients Enrolled in Cancer Therapeutic Trials: Observations From a 446-Patient Cohort

PubMed

PMC

QxMD

DOI

Google Scholar

Foster, Jared C. , Le-Rademacher, Jennifer G. ... - - Cancer - 2017

Manuscript - Primary Endpoint - Primary Analysis - Older Adult - ACOSOG-Z9001 , A151602 , NCCTG-97-24-51

Comparative nocebo findings in older patients enrolled in cancer therapeutic trials: observations from a 446-patient cohort (Alliance A151602)

Google Scholar

Foster, Jared C. , Le-Rademacher, Jennifer G. ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Primary Endpoint - Primary Analysis - Older Adult - A151602 , ACOSOG-Z9001 , NCCTG-97-24-51

Long-Term Follow-Up of TEXT and SOFT Trials of Adjuvant Endocrine Therapies for Premenopausal Women with HR+ Early Breast Cancer

DOI

Google Scholar

Francis, Prue , Fleming, Gini , Regan, Meredith , Pagani, Olivia ... - SABCS - Cancer Res - 2017

Abstract - Secondary Endpoint - Primary Analysis - Breast - IBCSG-24-02 (SOFT-TEXT)

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

PubMed

PMC

QxMD

DOI

Google Scholar

Freedman, Rachel A. , Foster, Jared C. , Seisler, Drew K. ... - - J. Clin. Oncol - 2017

Manuscript - Primary Endpoint - Comprehensive Analysis - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Fuchs, Charles S. , Niedzwiecki, Donna , Mamon, Harvey J. ... - - J. Clin. Oncol - 2017

Manuscript - Primary Endpoint - Primary Analysis - GI - CALGB-80101

Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Fuchs, M. A. , Yuan, C. , Sato, K. , Niedzwiecki, D. , Ye, X. ... - - Ann. Oncol - 2017

Manuscript - Secondary Endpoint - Primary Analysis - GI - CALGB-89803

Statistical modeling of CALGB 80405 (Alliance) to identify influential factors in metastatic colorectal cancer (CRC) dependent on primary tumor side.

Google Scholar

Furchtgott, Leon , Swanson, David , Hayete, Boris , Khalil, Iya ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405

NCCTG N1174: Phase I/Comparative Randomized Phase II Trial of TRC105 plus Bevacizumab versus Bevacizumab in Bevacizumab-Naïve Patients with Recurrent Glioblastoma Multiforme (Alliance)

Google Scholar

Galanis, Evanthia , Anderson, S. Keith , Butowski, Nicholas ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Primary Endpoint - Primary Analysis - Neuro-Onc - N1174

Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance)

Google Scholar

George, Daniel.J. , Halabi, Susan , Nixon, Andrew B. , Starr, Mark D. ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary Endpoint - Primary Analysis - Correl Sci NOS - CALGB-90206

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

PubMed

PMC

QxMD

DOI

Google Scholar

Giuliano, Armando E. , Ballman, Karla V. , McCall, Linda ... - - JAMA - 2017

Manuscript - Secondary Endpoint - Long-Term-Followup Analysis - Breast - ACOSOG-Z0011

Initial results of CALGB 80803: A randomized phase II trial of pet scan-directed combined modality therapy for esophageal cancer (Alliance)

Google Scholar

Goodman, Karyn A. , Niedzwiecki, Donna , Hall, Nathan ... - ASCO GI - J Clin Oncol - 2017

Abstract - Primary Endpoint - Preliminary Analysis - GI - CALGB-80803

Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration

DOI

Google Scholar

Grothey, Axel , Sobrero, Alberto F. , Meyerhardt, Jeffrey A. ... - ESMO - Annals of Oncology - 2017

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - CALGB-80702

Associations of Physical Activity with Survival and Progression in Metastatic Colorectal Cancer: Results from CALGB 80405 (Alliance)

Google Scholar

Guercio, Brendan J. , Venook, Alan P. , Niedzwiecki, Donna ... - ASCO GI - J Clin Oncol - 2017

Abstract - Secondary Endpoint - Preliminary Analysis - GI - CALGB-80405

Persistent Fatigue in Hematopoietic Stem Cell Transplantation Survivors

PubMed

PMC

QxMD

DOI

Google Scholar

Hacker, Eileen Danaher , Fink, Anne M. , Peters, Tara , Park, Chang ... - - Cancer Nurs - 2017

Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - Pilot

Real-Time Fatigue and Free-Living Physical Activity in Hematopoietic Stem Cell Transplantation Cancer Survivors and Healthy Controls: A Preliminary Examination of the Temporal, Dynamic Relationship

PubMed

PMC

QxMD

DOI

Google Scholar

Hacker, Eileen Danaher , Kim, Inah , Park, Chang ... - - Cancer Nurs - 2017

Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - Pilot

Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.

PubMed

PMC

QxMD

DOI

Google Scholar

Haricharan, Svasti , Punturi, Nindo , Singh, Purba ... - - Cancer Discov - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - ACOSOG-Z1031

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

PubMed

PMC

QxMD

DOI

Google Scholar

Himelstein, Andrew L. , Foster, Jared C. , Khatcheressian, James L. ... - - JAMA - 2017

Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - CALGB-70604 , CALGB-150804

Multivariate Analysis of Subtype and Gene Expression Signatures Predictive of Pathologic Complete Response (pCR) in Triple-Negative Breast Cancer (TNBC): CALGB 40603 (Alliance)

Google Scholar

Hoadley, Katherine A. , Hyslop, Terry , Fan, Cheng , Berry, Donald A. ... - SABCS - Cancer Res - 2017

Abstract - Secondary Endpoint - Primary Analysis - Correl Sci NOS - CALGB-40603

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma

PubMed

PMC

QxMD

DOI

Google Scholar

Holstein, Sarah A. , Jung, Sin-Ho , Richardson, Paul G. ... - - Lancet Haematol - 2017

Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Myeloma - CALGB-100104

Lymphedema, Musculoskeletal Events and Arm Function in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer (Alliance A171302)

PubMed

PMC

QxMD

DOI

Google Scholar

Hopkins, Judith O. , Allred, Jake , Hurria, Arti , Jatoi, Aminah ... - - Breast Cancer Res. Treat. - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - CALGB-49907 , A171302

Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group trial N0745 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Hubbard, Joleen M. , Mahoney, Michelle R. , Loui, William S. ... - - Target Oncol - 2017

Manuscript - Primary Endpoint - Primary Analysis - GI - N0745

Primary endocrine therapy for ER-positive ductal carcinoma in situ (DCIS) (Alliance) CALGB 40903

DOI

Google Scholar

Hwang, E. Shelley , Duong, Stephanie , Bedrosian, Isabelle ... - SABCS - Cancer Res - 2017

Abstract - Primary Endpoint - Primary Analysis - Breast - CALGB-40903

Somatic DNA mutations, mutational load (ML), and MSI status: association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance)

Google Scholar

Innocenti, Federico , Ou, Fang-Shu , Zemla, Tyler ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary Endpoint - Primary Analysis - Correl Sci NOS - CALGB-80405

Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Jansson-Knodell, Claire L. , Foster, Nathan R. , Sargent, Daniel J. ... - - J Gastrointest Oncol - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Prevention - N0147

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.

PubMed

PMC

QxMD

DOI

Google Scholar

Jatoi, A , Steen, P D , Atherton, P J , Moore, D F , Rowland, K M ... - - Ann. Oncol. - 2017

Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N02C4

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

PubMed

PMC

QxMD

DOI

Google Scholar

Katz, Matthew H. G. , Ou, Fang-Shu , Herman, Joseph M. ... - - BMC Cancer - 2017

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - GI - A021501

Alliance for clinical trials in oncology trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Google Scholar

Katz, Matthew , Herman, Joseph M. , Ou, Fang-Shu , Marsh, Robert ... - ASCO - J. Clin. Oncol. - 2017

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GI - A021501

Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS

PubMed

PMC

QxMD

DOI

Google Scholar

Kim, Kyu-pyo , Parise, Robert A. , Holleran, Julianne L. ... - - J Pharm Biomed Anal - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - A031201

A randomized phase II study of paclitaxel (P), carboplatin (C), bevacizumab (B) +/- everolimus (E) in metastatic melanoma (MM): secondary analysis of outcomes in patients who harbor an NRAS mutation NCCTG N0879 (Alliance).

Google Scholar

Kottschade, Lisa , Allred, Jacob , Rumila, K. , Markovic, Svetomir ... - SMR - - 2017

Abstract - Secondary Endpoint - Primary Analysis - Experimental - N0879

Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P) - based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC).

Google Scholar

Kozono, David E. , Salama, Joseph Kamel , Stinchcombe, Tom ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Primary Endpoint - Primary Analysis - Respiratory - AFT-07

An Analysis of Maintenance Therapy and Post-Midostaurin Outcomes in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603/RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations

Google Scholar

Larson, Richard A. , Mandrekar, Sumithra , Sanford, Ben L ... - ASH - Blood - 2017

Abstract - Secondary Endpoint - Primary Analysis - Leukemia - CALGB-10603

Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Le-Rademacher, Jennifer , Kanwar, Rahul , Seisler, Drew ... - - Support Care Cancer - 2017

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Symptom Inter - N08CA , N08CB

Association of micropapillary architecture and high tumor budding with prognosis in patients with stage III colon cancer from a FOLFOX-based adjuvant chemotherapy trial: NCCTG N0147 (Alliance)

Google Scholar

Lee, Hee Eun , Shi, Qian , Foster, Nate , Chan, Emily , Gill, Sharlene ... - USCAP - Mod Pathol - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - NCCTG-N0147

Impact of Consensus Molecular Subtyping (CMS) on overall survival (OS) and Progression Free Survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance).

Google Scholar

Lenz, Heinz-Josef , Ou, Fang-Shu , Venook, Alan P. ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - CALGB-80405

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial

PubMed

PMC

QxMD

DOI

Google Scholar

Lesurf, R. , Griffith, O. L. , Griffith, M. , Hundal, J. , Trani, L. ... - - Ann. Oncol - 2017

Manuscript - Secondary Endpoint - Primary Analysis - PPP - ACOSOG-Z1041

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

PubMed

PMC

QxMD

DOI

Google Scholar

Ligibel, Jennifer A. , Barry, William T. , Alfano, Catherine ... - - NPJ Breast Cancer - 2017

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - A011401

An mRNA Gene Expression–Based Signature to Identify FGFR1-Amplified Estrogen Receptor–Positive Breast Tumors

PubMed

PMC

QxMD

DOI

Google Scholar

Luo, Jingqin , Liu, Shuzhen , Leung, Samuel , Gru, Alejandro A. ... - - J Mol Diagn - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Correl Sci NOS - ACOSOG-Z1031

Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 / NCCTG N063H (Alliance)

DOI

Google Scholar

Magbanua, Mark Jesus M. , Hendrix, Laura , Hyslop, Terry ... - SABCS - Cancer Res - 2017

Abstract - Secondary Endpoint - Primary Analysis - Correl Sci NOS - CALGB-40502 , NCCTG-N063H

Frailty and Long-term Mortality Of Older Breast Cancer Patients: CALGB 369901 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Mandelblatt, Jeanne S. , Cai, Ling , Luta, George , Kimmick, Gretchen ... - - Breast Cancer Res. Treat. - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

PubMed

PMC

QxMD

DOI

Google Scholar

Mantha, Simon , Goldman, Debra A. , Devlin, Sean M. , Lee, Ju-Whei ... - - Blood - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - CALGB-9710

Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.

Google Scholar

Martin, Miguel , Loibl, Sibylle , Hyslop, Terry ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - CALGB-40503

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Martin, P , Jung, S -H , Pitcher, B , Bartlett, N L , Blum, K A ... - - Ann. Oncol - 2017

Manuscript - Primary Endpoint - Primary Analysis - Lymphoma - CALGB-50803

A phase I, open–label, multicenter trial of oral azacitidine (CC-486) plus R-CHOP in patients with high-risk, previously untreated diffuse large B-cell lymphoma, grade 3b follicular lymphoma, or transformed lymphoma (AFT-08)

Google Scholar

Martin, Peter , Bartlett, Nancy L. ... - ASH - Blood - 2017

Abstract - Primary Endpoint - Primary Analysis - Lymphoma - NCT02343536 , AFT-08

Final results of CALGB 50803 (Alliance): A phase 2 trial of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma

Google Scholar

Martin, Peter , Jung, Sin-Ho , Pitcher, Brandy , Bartlett, Nancy ... - ICML - Hemato Oncol - 2017

Abstract - Primary Endpoint - Long-Term-Followup Analysis - Lymphoma - CALGB-50803

Overall and Progression-Free Survival Adjusted for Treatment Crossover in the CALGB 100104 Study of Lenalidomide Versus Placebo Maintenance After Stem Cell Transplant for Patients With Newly Diagnosed Multiple Myeloma (Alliance)

Google Scholar

McCarthy, Philip L. , Holstein, Sarah A. , Jung, Sin-Ho ... - IMW - - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104

CALGB/ECOG 100104 (Alliance) Study: Lenalidomide (LEN) vs Placebo (PBO) Maintenance (Maint) After Stem Cell Transplant (SCT) for Patients (Pts) With Multiple Myeloma: Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment (Tx) Crossover (XO)

Google Scholar

McCarthy, Philip L. , Holstein, Sarah A. , Jung, Sin-Ho ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104

Lenalidomide vs Placebo Maintenance After Stem Cell Transplant for Patients With Multiple Myeloma: Overall Survival and Progression-Free Survival After Adjusting for Treatment Crossover in CALGB

Google Scholar

McCarthy, Philip L. , Holstein, Sarah A. , Jung, Sin-Ho ... - EHA - Haematologica - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

PubMed

PMC

QxMD

DOI

Google Scholar

McCarthy, Philip L. , Holstein, Sarah A. , Petrucci, Maria Teresa ... - - J. Clin. Oncol - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Myeloma - CALGB-100104

NCCTG N0543 (Alliance): A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma

PubMed

PMC

QxMD

DOI

Google Scholar

McWilliams, Robert R. , Foster, Nathan R. , Mahoney, Michelle R. ... - - Cancer - 2017

Manuscript - Primary Endpoint - Primary Analysis - GI - N0543

Kinetic-Pharmacodynamic Model of Chemotherapy Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel or Ixabepilone: CALGB 40502 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Mehrotra, Shailly , Sharma, Manish R. , Gray, Elizabeth , Wu, Kehua ... - - AAPS J - 2017

Manuscript - Secondary Endpoint - Primary Analysis - PPP - CALGB-40502

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Miyoshi, Jinsei , Toden, Shusuke , Yoshida, Kazuhiro , Toiyama, Yuji ... - - Sci Rep - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - N0147

Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L) or their combination (L+T) in the adjuvant treatment of HER2-positive early breast cancer

Google Scholar

Moreno-Aspitia, Alvaro , Holmes, Eileen , Jackisch, Christian ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N063D

Molecular landscape and clinical features of acute myeloid leukemia (AML) with complex karyotype (CK) CALGB 20202 and 8461 (Alliance)

Google Scholar

Mrózek, Krzysztof , Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461

Genetic correlates of therapeutic toxicities of stage III colon cancer (CC) patients treated with adjuvant FOLFOX+/-cetuximab (Alliance NCCTG N0147)

Google Scholar

Newcomb, Polly A. , Sun, Wei , Hua, Xinwei , Banbury, Barbara ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary Endpoint - Primary Analysis - PPP - NCCTG-N0147

A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803

PubMed

PMC

QxMD

DOI

Google Scholar

Niedzwiecki, Donna , Hasson, Rian M. , Lenz, Heinz‐Josef ... - - Oncologist - 2017

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - C89803 , C9581

Electronic Patient-Reported Outcomes and Toxicities During Radiotherapy for Head and Neck Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Niska, Joshua R. , Halyard, Michele Y. , Tan, Angelina D. ... - - Qual Life Res - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-892052

Addressing Tobacco Use Disparities in Rural Older Adults through a Mobile Phone Intervention: Project Wise

Google Scholar

Noonan, Devon , Silva, Susan , Fish, Laura , Simmons, Leigh Ann ... - RCC - - 2017

Abstract - Primary Endpoint - Primary Analysis - Prevention - NCT02510716

Addressing Tobacco Use Disparities in Rural Older Adults through a Mobile Phone Intervention: Project Wise

Google Scholar

Noonan, Devon , Silva, Susan , Njuru, J. , Bishop, T. , Fish, Laura J. ... - SRNT - - 2017

Abstract - Primary Endpoint - Primary Analysis - Prevention - NCT02510716

Axillary Management of Stage II/III Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-positive) and CALGB 40603 (Triple-negative)

PubMed

PMC

QxMD

DOI

Google Scholar

Ollila, David W , Cirrincione, Constance T , Berry, Donald A ... - - J. Am. Coll. Surg. - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - CALGB-40601 , CALGB-40603

Concomitant use of midostaurin with Strong CYP3A4 inhibitors: An analysis from the CALGB 10603/RATIFY Trial (Alliance)

Google Scholar

Ouatas, Taoufik , Duval, Vincent , Sinclair, Karen ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - CALGB-10603

Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance)

Google Scholar

Pang, Herbert , Yan, Kang , Kratzke, Robert , Stinchcombe, Thomas ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint Endpoint - Comprehensive Analysis - Respiratory - CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733

Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia

PubMed

PMC

QxMD

DOI

Google Scholar

Papaioannou, Dimitrios , Nicolet, Deedra , Volinia, Stefano ... - - Haematologica - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-10503 , CALGB-10603 , CALGB-19808 , CALGB-20202 , CALGB-8461 , CALGB-8525 , CALGB-9022 , CALGB-9222 , CALGB-9621 , CALGB-9665

Recurrent Genetic Variants of Long Non-Coding RNAs Independently Associate with Clinical Outcome of Younger Adults with Cytogenetically Normal Acute Myeloid Leukemia (ALLIANCE/CALGB 8461, 9665, 20202)

Google Scholar

Papaioannou, Dimitrios , Ozer, Gulcin H. , Nicolet, Deedra ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia

PubMed

PMC

QxMD

DOI

Google Scholar

Prevention of Lymphedema in Women with Breast Cancer: Results of CALGB 70305 (Alliance)

Google Scholar

Paskett, Electra , Oliveri, Jill , Le-Rademacher, Jennifer ... - ASCO CSS - J. Clin. Oncol. - 2017

Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - CALGB-70305

Pre-diagnostic physical activity and outcomes in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)

Google Scholar

Phipps, Amanda I. , Shi, Qian , Chan, Emily , Gill, Sharlene ... - ASPO - - 2017

Abstract - Secondary Endpoint - Primary Analysis - GI - NCCTG-N0147

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT

PubMed

PMC

QxMD

DOI

Google Scholar

Regan, M. M. , Walley, B. A. , Francis, P. A. , Fleming, G. F. ... - - Ann. Oncol - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Breast - IBCSG-24-02 (SOFT-TEXT)

IGF1R Protein Expression is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2-positive Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831

PubMed

PMC

QxMD

DOI

Google Scholar

Reinholz, Monica M. , Chen, Beiyun , Dueck, Amylou C. ... - - Clin. Cancer Res. - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Breast - NCCTG-N9831

The effects of treatment-induced symptoms, depression and age on sexuality in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

DOI

Google Scholar

Ribi, Karin , Luo, Weixiu , Burstein, Harold J. ... - SABCS - Cancer Research - 2017

Abstract - Secondary Endpoint - Primary Analysis - Breast - IBCSG-24-02 (SOFT-TEXT)

N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group): Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease: Cognitive function of long-term survivors

Google Scholar

Roberge, David , Ballman, Karla V. , Cerhan, Jane H. ... - SNO - Neuro-Oncology - 2017

Abstract - Secondary Endpoint - Primary Analysis - Neuro-Onc - N107C

Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Google Scholar

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Respiratory - AFT-16

A Genetic Risk-Stratified, Phase II Study of Fludarabine/Antibody Combinations in Symptomatic, Untreated Chronic Lymphocytic Leukemia (CLL): Final Results of Cancer and Leukemia Group B (CALGB) 10404 (Alliance)

Google Scholar

Ruppert, Amy S. , Byrd, John C. , Heerema, Nyla A. , Smith, Mitchell ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Primary Endpoint - Primary Analysis - Leukemia - CALGB-10404

Serum Androgens and Survival in metastatic Castration Resistant Prostate Cancer (mCRPC) Patients Treated with Docetaxel and Prednisone: Results from CALGB 90401 (Alliance)

Google Scholar

Ryan, Charles J , Dutta, Sandipan , Kelly, William K ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90401

Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601

PubMed

PMC

QxMD

DOI

Google Scholar

SMITH, E.M.L. , PANG, H. , YE, C. , CIRRINCIONE, C. , FLEISHMAN, S. ... - - Eur J Cancer Care (Engl) - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-170601

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Saha, Poornima , Regan, Meredith M. , Pagani, Olivia ... - - J. Clin. Oncol - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Breast - IBCSG-24-02 (SOFT-TEXT)

Long-terms results of a trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small cell lung cancer: NCCTG N0028 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Schild, Steven E. , Hillman, Shauna L. , Tan, Angelina D. ... - - J Thorac Oncol - 2017

Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - NCCTG-N0028

High proliferation by the MCL35 assay is associated with inferior outcomes in patients treated with intensive regimens – a correlative study from the Alliance 50403 trial.

Google Scholar

Scott, David W. , Pitcher, Brandelyn , Liu, Yi Tian , Boyle, Merrill ... - ICML - Hematol Oncol - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - CALGB-50403

Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Shapiro, Charles L. , Moriarty, James P. , Dusetzina, Stacie ... - - J. Clin. Oncol - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - CALGB-70604

Prospective pooled analysis of six phase III trials investigating duration of adjuvant oxaliplatin-based therapy (3 versus 6 months) for patients with stage III colon cancer: The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration (Alliance)

Google Scholar

Shi, Qian , Sobrero, Alberto , Shields, Anthony , Yoshino, Takayuki ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80702

Randomized Trial of FOLFOX Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability (ATOMIC, Alliance A021502)

Google Scholar

Sinicrope FA , Ou, F-S , Shi, Q , Nixon, A , Kabir Mody ... - ASCO - J. Clin. Oncol. - 2017

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GI - A021502

Association of DNA Mismatch Repair and Mutations in BRAF and KRAS with Survival after Recurrence in Stage III Colon Cancers from Phase III Adjuvant Chemotherapy Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Sinicrope, Frank A. , Shi, Qian , Allegra, Carmen J. ... - - JAMA Oncol - 2017

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Correl Sci NOS - NCCTG-N0147

Prognostic utility of immune markers and validation of Immunoscore in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance)

DOI

Google Scholar

Sinicrope, Frank A. , Shi, Qian , Hermitte, Fabienne ... - ESMO GI - Annals of Oncology - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N0147

Association of an immunoscore with survival of stage III colon cancer (CC) patients treated with adjuvant FOLFOX (Alliance N0147)

Google Scholar

Sinicrope, Frank A. , Shi, Qian , Hermitte, Fabienne , Heying, Erica ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - NCCTG-N0147

Analysis of serum vitamin D levels and prognosis in stage III colon carcinoma patients treated with adjuvant FOLFOX+/- cetuximab chemotherapy (NCCTG N0147) (Alliance)

Google Scholar

Sinicrope, Frank A. , Shi, Qian , Smyrk, Thomas C. ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary Endpoint - Primary Analysis - Correl Sci NOS - NCCTG-N0147

Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients

PubMed

PMC

QxMD

Google Scholar

Sloan, Jeff A. , Liu, H. , Satele, D.V. , Puttabasavaiah, S. ... - - Trends Cancer Res - 2017

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - N0591

Safety and Tolerability of Idelalisib, Lenalidomide, and Rituximab in Relapsed and Refractory Lymphoma: Alliance A051201 and A051202 Phase I Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Smith, Sonali M. , Pitcher, Brandelyn N. , Jung, Sin-Ho ... - - Lancet Haematol - 2017

Manuscript - Primary Endpoint - Primary Analysis - Lymphoma - A051201 , A051202

Marine omega-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis

PubMed

PMC

QxMD

DOI

Google Scholar

Song, Mingyang , Zhang, Xuehong , Meyerhardt, Jeffrey A. ... - - Gut - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - N0147

Effects of age, immune landscape, and response to trastuzumab (H) in HER-2 positive (HER2+) breast cancer in NCCTG (Alliance)-N9831.

DOI

Google Scholar

Soyano, Aixa Elena , Serie, Daniel , Mashadi-Hossein, Afshin ... - ASCO - JCO - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N9831

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

PubMed

PMC

QxMD

DOI

Google Scholar

Stone, Richard M. , Mandrekar, Sumithra J. , Sanford, Ben L. ... - - N. Engl. J. Med. - 2017

Manuscript - Primary Endpoint - Primary Analysis - Leukemia - CALGB-10603

The Addition of Midostaurin to Standard Chemotherapy Decreases Cumulative Incidence of Relapse (CIR) in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603 / RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations

Google Scholar

Stone, Richard M. , Mandrekar, Sumithra , Sanford, Ben L ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Leukemia - CALGB-10603

Integrated Analysis of Multidimensional Genomic Data on CALGB 40601 (Alliance), a Randomized Neoadjuvant Phase III Trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-Positive Breast Cancer

Google Scholar

Tanioka, Maki , Fan, Chen , Carey, Lisa A. , Hyslop, Terry ... - SABCS - Cancer Res - 2017

Abstract - Secondary Endpoint - Primary Analysis - Sequencing - CALGB-40601

A pilot, randomized trial of daily lisinopril vs placebo to prevent radiation-induced pulmonary distress (Alliance MC1221)

Google Scholar

Terence T. Sio , Pamela J. Atherton , W. Ken Zhen , Yolanda I. Garces ... - IASLC (WCLC) - - 2017

Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01880528

Beyond maximum grade: A novel, longitudinal toxicity over time (ToxT) adverse event analysis of lenalidomide in follicular lymphoma in Alliance A151617

Google Scholar

Thanarajasingam, Gita , Dueck, Amylou , Novotny, Paul J. ... - ICML - Hematol Oncol - 2017

Abstract - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-50401 , A151617

PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Tsao, M.-S. , Le Teuff, G. , Shepherd, F. A. , Landais, C. ... - - Ann. Oncol - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001

PubMed

PMC

QxMD

DOI

Google Scholar

Uy, Geoffrey L. , Mandrekar, Sumithra J. , Laumann, Kristina ... - - Blood Adv - 2017

Manuscript - Primary Endpoint - Primary Analysis - Leukemia - CALGB-11001

American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance)

Google Scholar

Van Blarigan, Erin L , Fuchs, Charles S. , Niedzwiecki, Donna ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary Endpoint - Primary Analysis - GI - CALGB-89803

Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival CALGB 89803 (Alliance)

Google Scholar

Van Blarigan, Erin L , Fuchs, Charles S. , Niedzwiecki, Donna ... - ASCO GI - J Clin Oncol - 2017

Abstract - Secondary Endpoint - Primary Analysis - GI - CALGB-89803

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Venook, Alan P. , Niedzwiecki, Donna , Lenz, Heinz-Josef ... - - JAMA - 2017

Manuscript - Primary Endpoint - Primary Analysis - GI - CALGB-80405

Primary (1°) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance)

Google Scholar

Venook, Alan P. , Ou, Fang-Shu , Innocenti, Federico ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary Endpoint - Primary Analysis - GI - CALGB-80405

Receptor Activator of Nuclear Factor Kappa B (RANK) Expression in Primary Breast Cancer Correlates with Recurrence Free Survival and Development of Bone Metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657)

PubMed

PMC

QxMD

DOI

Google Scholar

Vidula, Neelima , Yau, Christina , Li, Jiali , Esserman, Laura J. ... - - Breast Cancer Res. Treat. - 2017

Manuscript - Secondary Endpoint - Primary Analysis - Breast - CALGB-150007

Interim safety analysis of a phase 2 randomized study of daratumumab (dara), lenalidomide (r), bortezomib (v), and dexamethasone (d; dara‐rvd) vs. rvd in patients (pts) with newly diagnosed multiple myeloma (mm) eligible for high‐dose therapy (hdt) and autologous stem cell transplantation (asct)

Google Scholar

Voorhees, Peter M. , MD , Costa, Luciano J. , PhD , Reeves, Brandi ... - ASH - Blood - 2017

Abstract - Secondary Endpoint - Preliminary Analysis - Myeloma - AFT-29

No evidence for microsatellite instability in acute myeloid leukemia

PubMed

PMC

QxMD

DOI

Google Scholar

Walker, Christopher J. , Eisfeld, Ann-Kathrin , Genutis, Luke K. ... - - Leukemia - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Wang, Xiaofei , Wang, Xiaoyi , Hodgson, Lydia , George, Stephen L. ... - - Oncologist - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - C8435 , C8638 , C8833 , C8933 , C9031 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , N0021 , NCCTG-N0623

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Witzig, T E , LaPlant, B , Habermann, T M , McPhail, E , Inwards, D J ... - - Blood Cancer J - 2017

Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Lymphoma - N1085